A new eBook by Elation Health offers a checklist to help primary care practices maintain and grow in the face of these myriad challenges. The post A Strategic Growth Plan for Primary Care Practices appeared first on MedCity News.
Tim Sheehy “would let politicians like him ban abortion, with no exceptions for rape or to save a woman’s life, and criminalize women.” A Facebook ad from the campaign of Sen. Jon Tester (D-Mont.), launched on Sept. 6, 2024 In a race that could decide control of the U.S. Senate, Sen. Jon Tester (D-Mont.) is…
Ionis Pharmaceuticals plans a 2026 FDA submission for zilganersen as a treatment for Alexander disease, an ultra-rare inherited neurological disorder. The antisense oligonucleotide developer has been moving toward commercializing drugs on its own rather than seeking partners. The post Ionis Pharma’s Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study appeared…
Join us Thursday, October 24, at 1pm ET for a webinar sponsored by Personify Health on how employers navigate the intricate challenges posed by rising healthcare costs while prioritizing employee health and well-being. The post How Do Employers Address Rising Healthcare Costs? appeared first on MedCity News.
The Phase 3 results in China are encouraging for Kailera Therapeutics, which holds rights to the molecule in the rest of the world. The startup is preparing a global clinical development program for this drug, a once-weekly injectable GLP-1 and GIP receptor agonist. The post Hengrui Pharma’s Potential Rival to El Lilly’s Zepbound Leads to…
Conventional wisdom holds that it takes 17 years from medical innovation to adoption in the real-world. However, with advances in information technology, perhaps adoption timelines have shortened. A paper by DiCicca et al. (2024) examines how new clinical trial evidence on breech births impact practice patterns. Specifically, they note that: Using the United States Birth…
The US’s withdrawal from the WHO marks a significant shift in global health diplomacy
The growing use of advanced analytics and artificial intelligence (AI) is reshaping this landscape by enabling data-driven process control, predictive manufacturing, and greater transparency across the development lifecycle. The post Data at Work: How Advanced Analytics Are Transforming Cell and Gene Therapy Manufacturing appeared first on MedCity News.
Merck is acquiring global rights to a bispecific antibody from LaNova Medicines that blocks two cancer targets, PD-1 and VEGF. The deal comes one day after BioNTech announced an $800 million acquisition that gives it full rights to a molecule in this hot class of cancer drug candidates. The post Merck Is Paying $588M for…
From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference. The post 3 Health Investors Share Their Most Controversial Industry Takes appeared first on MedCity News.